mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.004 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.006 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.006 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |